Published in Sci Rep on April 21, 2017
Identification of c-MYC as a target of the APC pathway. Science (1998) 24.25
The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci U S A (1999) 10.75
The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell (1997) 6.10
Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC. Nat Cell Biol (2001) 3.26
Wnt signaling mediates self-organization and axis formation in embryoid bodies. Cell Stem Cell (2008) 2.64
Dickkopf-1 (DKK1) reveals that fibronectin is a major target of Wnt signaling in branching morphogenesis of the mouse embryonic lung. Dev Biol (2005) 2.23
Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome. Am J Pathol (2010) 2.20
Transactivation of vimentin by beta-catenin in human breast cancer cells. Cancer Res (2003) 2.20
Delta N89 beta-catenin induces precocious development, differentiation, and neoplasia in mammary gland. J Cell Biol (2001) 2.18
Nuclear-cytoplasmic shuttling of Axin regulates subcellular localization of beta-catenin. Proc Natl Acad Sci U S A (2004) 1.89
Characterization of the localization and proteolytic activity of the SUMO-specific protease, SENP1. J Biol Chem (2003) 1.88
Sumoylation is involved in beta-catenin-dependent activation of Tcf-4. EMBO J (2003) 1.61
RNA sequencing of cancer reveals novel splicing alterations. Sci Rep (2013) 1.57
SUMO Losing Balance: SUMO Proteases Disrupt SUMO Homeostasis to Facilitate Cancer Development and Progression. Genes Cancer (2010) 1.42
siRNA off-target effects in genome-wide screens identify signaling pathway members. Sci Rep (2012) 1.41
Nucleocytoplasmic shuttling modulates activity and ubiquitination-dependent turnover of SUMO-specific protease 2. Mol Cell Biol (2006) 1.29
SENP1 induces prostatic intraepithelial neoplasia through multiple mechanisms. J Biol Chem (2010) 1.29
SUMO-1 modification of the C-terminal KVEKVD of Axin is required for JNK activation but has no effect on Wnt signaling. J Biol Chem (2002) 1.20
Expression patterns of beta-catenin in in situ and invasive breast cancer. Eur J Surg Oncol (2001) 1.12
Differential expression of SUMO-specific protease 7 variants regulates epithelial-mesenchymal transition. Proc Natl Acad Sci U S A (2012) 1.05
The SUMO protease SENP7 is a critical component to ensure HP1 enrichment at pericentric heterochromatin. Nat Struct Mol Biol (2012) 0.99
Myc is required for β-catenin-mediated mammary stem cell amplification and tumorigenesis. Mol Cancer (2013) 0.96
The deSUMOylase SENP7 promotes chromatin relaxation for homologous recombination DNA repair. EMBO Rep (2013) 0.91
System-wide identification of wild-type SUMO-2 conjugation sites. Nat Commun (2015) 0.90
β-catenin links von Hippel-Lindau to aurora kinase A and loss of primary cilia in renal cell carcinoma. J Am Soc Nephrol (2014) 0.86
Regulation of glycogen synthase kinase 3beta functions by modification of the small ubiquitin-like modifier. Open Biochem J (2008) 0.83
The in vivo functions of desumoylating enzymes. Subcell Biochem (2010) 0.81
SUMOylation of HP1α supports association with ncRNA to define responsiveness of breast cancer cells to chemotherapy. Oncotarget (2016) 0.80
β-catenin SUMOylation is involved in the dysregulated proliferation of myeloma cells. Am J Cancer Res (2014) 0.78
Isolation of In Vivo SUMOylated Chromatin-Bound Proteins. Methods Mol Biol (2016) 0.77